Overview
Lobbying Costs
700,000€ - 799,999€
Financial year: Jan 2023 - Dec 2023
Lobbyists (Full time equivalent)
3.45 Fte (7)
Lobbyists with EP accreditation
1
High-level Commission meetings
7
Lobbying Costs over the years
-
Info
AstraZeneca PLC
EU Transparency Register
249402638316-62 First registered on 28 May 2020
Goals / Remit
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines in Oncology and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
Main EU files targeted
Our engagement with the EU institutions focuses, among others, on the following topics:
- Healthcare
- Pharmaceutical policy
- R&D
- Trade
- Sustainability
- Environment
- Public Health
- Industrial Policy
- Intellectual PropertyAddress
Head Office
1 Francis Crick Avenue Cambridge Biomedical Campus
Cambridge CB2 0AA
UNITED KINGDOMEU Office
29-33 Rue Des Deux Eglises
Brussels 1000
BELGIUMWebsite
-
People
Total lobbyists declared
7
Employment time Lobbyists 100% 2 75% 1 25% 2 10% 2 Lobbyists (Full time equivalent)
3.45
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
1 accreditations were / are live (in bold) for the selected state of 27 Apr 2024
Name Start date End Date Ava LLOYD 20 Mar 2024 02 Oct 2024 Ms Ava Lloyd 20 Mar 2024 15 Apr 2024 Complementary Information
None declared
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Companies & groups
-
Networking
Affiliation
European Federation of Pharmaceutical Industries and Associations (EFPIA) - www.efpia.eu
International Pharmaceutical Aerosol Consortium (IPAC) - www.ipacinhaler.org
European Roundtable For Industry (ERT) - www.ert.euMember organisations
European Policy Centre https://epc.eu/en/
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Jan 2023 - Dec 2023
Lobbying costs for closed financial year
700,000€ - 799,999€
Major contributions in closed year
None declared
Intermediaries for closed year
Name Amount edelman public relations worldwide 100,000€ - 199,999€ kreab worldwide 100,000€ - 199,999€ flint europe 200,000€ - 299,999€ acumen public affairs 50,000€ - 99,999€ Intermediaries for current year
Name edelman public relations worldwide kreab worldwide flint europe Closed year Costs
700,000€ - 799,999€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
N/A
Communication activities
Engaging with EU policy makers and stakeholders.
Other activities
None declared
Meetings
Meetings
7 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
-
Date 12 Apr 2021 Location Brussels Subject Vaccine production and delivery schedule for Q2 2021 Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Maurits-Jan Prinz (Cabinet member)
-
Date 11 Apr 2021 Location Videocall Subject Vaccine production and deliveries Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
-
Date 11 Feb 2021 Location webex Subject vaccines - delivery schedule DG Health and Food Safety Attending - Sandra Gallina (Director-General)
-
Date 01 Feb 2021 Location webex Subject vaccines DG Health and Food Safety Attending - Sandra Gallina (Director-General)
-
Date 31 Jan 2021 Location Videoconference Subject Meeting with CEOs of the pharmaceutical companies with which the Commission has signed Advance Purchase Agreements Cabinet Cabinet of President Ursula von der Leyen Portfolio President Attending - Ursula von der Leyen (President)
Other Lobbyists -
Date 21 Jan 2021 Location webex Subject follow up vaccines DG Health and Food Safety Attending - Sandra Gallina (Director-General)
-
Date 11 Jan 2021 Location Skype Subject Follow-up over vaccines DG Health and Food Safety Attending - Sandra Gallina (Director-General)